United States Neurological Biomarkers Market Report 2017

December 2017 | 111 pages | ID: U75D5C1BCE9EN
QYResearch

Abstracts

In this report, the United States Neurological Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Neurological Biomarkers in these regions, from 2012 to 2022 (forecast).

United States Neurological Biomarkers market competition by top manufacturers/players, with Neurological Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Thermo Fisher Scientific (U.S.)
• Qiagen (Germany)
• Myriad RBM (U.S.)
• Proteome Sciences (UK)
• Banyan Biomarkers (U.S.)
• Cisbio Bioassays (U.S.)
• Abiant (U.S.)
• Acumen Pharmaceuticals (U.S.)
• Proteosys (Germany)
• Alseres Pharmaceuticals (U.S.)
• Athena Diagnostics (U.S.)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Alzheimer's Disease
• Parkinson's Disease
• Autism Spectrum Disorder
• Multiple Sclerosis
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Genomics
• Proteomics
• Metabolomics
• Imaging
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Neurological Biomarkers Market Report 2017

1 NEUROLOGICAL BIOMARKERS OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Product Category
  1.2.1 United States Neurological Biomarkers Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Neurological Biomarkers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Alzheimer's Disease
  1.2.4 Parkinson's Disease
  1.2.5 Autism Spectrum Disorder
  1.2.6 Multiple Sclerosis
  1.2.7 Other
1.3 United States Neurological Biomarkers Market by Application/End Users
  1.3.1 United States Neurological Biomarkers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Genomics
  1.3.3 Proteomics
  1.3.4 Metabolomics
  1.3.5 Imaging
  1.3.6 Other
1.4 United States Neurological Biomarkers Market by Region
  1.4.1 United States Neurological Biomarkers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.3 Southwest Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.5 New England Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.6 The South Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.7 The Midwest Neurological Biomarkers Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Neurological Biomarkers (2012-2022)
  1.5.1 United States Neurological Biomarkers Sales and Growth Rate (2012-2022)
  1.5.2 United States Neurological Biomarkers Revenue and Growth Rate (2012-2022)

2 UNITED STATES NEUROLOGICAL BIOMARKERS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Neurological Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Neurological Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Neurological Biomarkers Average Price by Players/Suppliers (2012-2017)
2.4 United States Neurological Biomarkers Market Competitive Situation and Trends
  2.4.1 United States Neurological Biomarkers Market Concentration Rate
  2.4.2 United States Neurological Biomarkers Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neurological Biomarkers Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEUROLOGICAL BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Neurological Biomarkers Sales and Market Share by Region (2012-2017)
3.2 United States Neurological Biomarkers Revenue and Market Share by Region (2012-2017)
3.3 United States Neurological Biomarkers Price by Region (2012-2017)

4 UNITED STATES NEUROLOGICAL BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Neurological Biomarkers Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
4.3 United States Neurological Biomarkers Price by Type (2012-2017)
4.4 United States Neurological Biomarkers Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NEUROLOGICAL BIOMARKERS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Neurological Biomarkers Sales and Market Share by Application (2012-2017)
5.2 United States Neurological Biomarkers Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUROLOGICAL BIOMARKERS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Thermo Fisher Scientific (U.S.)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neurological Biomarkers Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Qiagen (Germany)
  6.2.2 Neurological Biomarkers Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Qiagen (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Myriad RBM (U.S.)
  6.3.2 Neurological Biomarkers Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Myriad RBM (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Proteome Sciences (UK)
  6.4.2 Neurological Biomarkers Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Proteome Sciences (UK) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Banyan Biomarkers (U.S.)
  6.5.2 Neurological Biomarkers Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Banyan Biomarkers (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Cisbio Bioassays (U.S.)
  6.6.2 Neurological Biomarkers Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cisbio Bioassays (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abiant (U.S.)
  6.7.2 Neurological Biomarkers Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abiant (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Acumen Pharmaceuticals (U.S.)
  6.8.2 Neurological Biomarkers Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Proteosys (Germany)
  6.9.2 Neurological Biomarkers Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Proteosys (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Alseres Pharmaceuticals (U.S.)
  6.10.2 Neurological Biomarkers Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Athena Diagnostics (U.S.)

7 NEUROLOGICAL BIOMARKERS MANUFACTURING COST ANALYSIS

7.1 Neurological Biomarkers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neurological Biomarkers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neurological Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Neurological Biomarkers Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Neurological Biomarkers Sales Volume Forecast by Type (2017-2022)
11.3 United States Neurological Biomarkers Sales Volume Forecast by Application (2017-2022)
11.4 United States Neurological Biomarkers Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neurological Biomarkers
Figure United States Neurological Biomarkers Market Size (K Pcs) by Type (2012-2022)
Figure United States Neurological Biomarkers Sales Volume Market Share by Type (Product Category) in 2016
Figure Alzheimer's Disease Product Picture
Figure Parkinson's Disease Product Picture
Figure Autism Spectrum Disorder Product Picture
Figure Multiple Sclerosis Product Picture
Figure Other Product Picture
Figure United States Neurological Biomarkers Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Neurological Biomarkers by Application in 2016
Figure Genomics Examples
Table Key Downstream Customer in Genomics
Figure Proteomics Examples
Table Key Downstream Customer in Proteomics
Figure Metabolomics Examples
Table Key Downstream Customer in Metabolomics
Figure Imaging Examples
Table Key Downstream Customer in Imaging
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Neurological Biomarkers Market Size (Million USD) by Region (2012-2022)
Figure The West Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neurological Biomarkers Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Neurological Biomarkers Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Neurological Biomarkers Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neurological Biomarkers Sales Share by Players/Suppliers
Figure 2017 United States Neurological Biomarkers Sales Share by Players/Suppliers
Figure United States Neurological Biomarkers Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Neurological Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Neurological Biomarkers Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neurological Biomarkers Revenue Share by Players/Suppliers
Figure 2017 United States Neurological Biomarkers Revenue Share by Players/Suppliers
Table United States Market Neurological Biomarkers Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Neurological Biomarkers Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Neurological Biomarkers Market Share of Top 3 Players/Suppliers
Figure United States Neurological Biomarkers Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neurological Biomarkers Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neurological Biomarkers Product Category
Table United States Neurological Biomarkers Sales (K Pcs) by Region (2012-2017)
Table United States Neurological Biomarkers Sales Share by Region (2012-2017)
Figure United States Neurological Biomarkers Sales Share by Region (2012-2017)
Figure United States Neurological Biomarkers Sales Market Share by Region in 2016
Table United States Neurological Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Neurological Biomarkers Revenue Share by Region (2012-2017)
Figure United States Neurological Biomarkers Revenue Market Share by Region (2012-2017)
Figure United States Neurological Biomarkers Revenue Market Share by Region in 2016
Table United States Neurological Biomarkers Price (USD/Pcs) by Region (2012-2017)
Table United States Neurological Biomarkers Sales (K Pcs) by Type (2012-2017)
Table United States Neurological Biomarkers Sales Share by Type (2012-2017)
Figure United States Neurological Biomarkers Sales Share by Type (2012-2017)
Figure United States Neurological Biomarkers Sales Market Share by Type in 2016
Table United States Neurological Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Type (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Type in 2016
Table United States Neurological Biomarkers Price (USD/Pcs) by Types (2012-2017)
Figure United States Neurological Biomarkers Sales Growth Rate by Type (2012-2017)
Table United States Neurological Biomarkers Sales (K Pcs) by Application (2012-2017)
Table United States Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Neurological Biomarkers Sales Market Share by Application in 2016
Table United States Neurological Biomarkers Sales Growth Rate by Application (2012-2017)
Figure United States Neurological Biomarkers Sales Growth Rate by Application (2012-2017)
Table Thermo Fisher Scientific (U.S.) Basic Information List
Table Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Qiagen (Germany) Basic Information List
Table Qiagen (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Myriad RBM (U.S.) Basic Information List
Table Myriad RBM (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Proteome Sciences (UK) Basic Information List
Table Proteome Sciences (UK) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Banyan Biomarkers (U.S.) Basic Information List
Table Banyan Biomarkers (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Cisbio Bioassays (U.S.) Basic Information List
Table Cisbio Bioassays (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Abiant (U.S.) Basic Information List
Table Abiant (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Acumen Pharmaceuticals (U.S.) Basic Information List
Table Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Proteosys (Germany) Basic Information List
Table Proteosys (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Alseres Pharmaceuticals (U.S.) Basic Information List
Table Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales Market Share in United States (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Market Share in United States (2012-2017)
Table Athena Diagnostics (U.S.) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarkers Major Players/Suppliers in 2016
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders List
Figure United States Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Neurological Biomarkers Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Neurological Biomarkers Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Neurological Biomarkers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neurological Biomarkers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neurological Biomarkers Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources